Human NAD(P)H: quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan

Yuan Hung Wang, Ying Huei Lee, Po Tsang Tseng, Cheng Huang Shen, Hung Yi Chiou

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: To investigate whether the NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms are associated with urothelial cancer (UC) risk in Taiwan. Methods: In this study, 600 study subjects (including 300 UC patients and 300 cancer-free controls) were recruited from September 1998 to December 2005. We analyzed the NQO1 and SULT1A1 polymorphisms by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. A comprehensive interview was conducted to collect information, including baseline characteristics and cigarette smoking status. We used an unconditional multivariate logistic regression to calculate the odds ratio (OR) and 95% confidence interval (CI). Results: We found a significantly increased UC risk in study subjects with the NQO1 C/T and T/T genotypes (OR = 1.5; 95% CI: 1.03-2.1). A significantly increased UC risk was found in those with the SULT1A1 G/G genotype (OR = 2.0; 95% CI: 1.3-3.2). Subjects who had ever smoked with either the NQO1 C/T and T/T genotypes or the SULT1A1 G/G genotype had significantly increased UC risks, showing ORs of 3.0 and 5.3, respectively. Subjects carrying both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had a significantly increased UC risk (OR = 3.7; 95% CI, 1.4-9.7). Moreover, those who had ever smoked with both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had the highest UC risk (OR = 8.6; 95% CI: 2.5-29.7). Conclusions: These findings suggest that NQO1 and SULT1A1 polymorphisms are associated with the risk of UC, particularly among those who have ever smoked.

Original languageEnglish
Pages (from-to)203-209
Number of pages7
JournalJournal of Cancer Research and Clinical Oncology
Volume134
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Sulfotransferases
Taiwan
Genotype
Odds Ratio
Neoplasms
Confidence Intervals
human NQO1 protein
Restriction Fragment Length Polymorphisms
NAD
Oxidoreductases
Logistic Models
Smoking
Interviews
Polymerase Chain Reaction

Keywords

  • Cigarette smoking
  • NAD(P)H:quinone oxidoreductase 1
  • Sulfotransferase 1A1
  • Urothelial cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Human NAD(P)H : quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan. / Wang, Yuan Hung; Lee, Ying Huei; Tseng, Po Tsang; Shen, Cheng Huang; Chiou, Hung Yi.

In: Journal of Cancer Research and Clinical Oncology, Vol. 134, No. 2, 02.2008, p. 203-209.

Research output: Contribution to journalArticle

@article{8964d81111e04458ac7064c7b2dd7820,
title = "Human NAD(P)H: quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan",
abstract = "Purpose: To investigate whether the NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms are associated with urothelial cancer (UC) risk in Taiwan. Methods: In this study, 600 study subjects (including 300 UC patients and 300 cancer-free controls) were recruited from September 1998 to December 2005. We analyzed the NQO1 and SULT1A1 polymorphisms by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. A comprehensive interview was conducted to collect information, including baseline characteristics and cigarette smoking status. We used an unconditional multivariate logistic regression to calculate the odds ratio (OR) and 95{\%} confidence interval (CI). Results: We found a significantly increased UC risk in study subjects with the NQO1 C/T and T/T genotypes (OR = 1.5; 95{\%} CI: 1.03-2.1). A significantly increased UC risk was found in those with the SULT1A1 G/G genotype (OR = 2.0; 95{\%} CI: 1.3-3.2). Subjects who had ever smoked with either the NQO1 C/T and T/T genotypes or the SULT1A1 G/G genotype had significantly increased UC risks, showing ORs of 3.0 and 5.3, respectively. Subjects carrying both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had a significantly increased UC risk (OR = 3.7; 95{\%} CI, 1.4-9.7). Moreover, those who had ever smoked with both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had the highest UC risk (OR = 8.6; 95{\%} CI: 2.5-29.7). Conclusions: These findings suggest that NQO1 and SULT1A1 polymorphisms are associated with the risk of UC, particularly among those who have ever smoked.",
keywords = "Cigarette smoking, NAD(P)H:quinone oxidoreductase 1, Sulfotransferase 1A1, Urothelial cancer, Cigarette smoking, NAD(P)H:quinone oxidoreductase 1, Sulfotransferase 1A1, Urothelial cancer",
author = "Wang, {Yuan Hung} and Lee, {Ying Huei} and Tseng, {Po Tsang} and Shen, {Cheng Huang} and Chiou, {Hung Yi}",
year = "2008",
month = "2",
doi = "10.1007/s00432-007-0271-4",
language = "English",
volume = "134",
pages = "203--209",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Human NAD(P)H

T2 - quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan

AU - Wang, Yuan Hung

AU - Lee, Ying Huei

AU - Tseng, Po Tsang

AU - Shen, Cheng Huang

AU - Chiou, Hung Yi

PY - 2008/2

Y1 - 2008/2

N2 - Purpose: To investigate whether the NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms are associated with urothelial cancer (UC) risk in Taiwan. Methods: In this study, 600 study subjects (including 300 UC patients and 300 cancer-free controls) were recruited from September 1998 to December 2005. We analyzed the NQO1 and SULT1A1 polymorphisms by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. A comprehensive interview was conducted to collect information, including baseline characteristics and cigarette smoking status. We used an unconditional multivariate logistic regression to calculate the odds ratio (OR) and 95% confidence interval (CI). Results: We found a significantly increased UC risk in study subjects with the NQO1 C/T and T/T genotypes (OR = 1.5; 95% CI: 1.03-2.1). A significantly increased UC risk was found in those with the SULT1A1 G/G genotype (OR = 2.0; 95% CI: 1.3-3.2). Subjects who had ever smoked with either the NQO1 C/T and T/T genotypes or the SULT1A1 G/G genotype had significantly increased UC risks, showing ORs of 3.0 and 5.3, respectively. Subjects carrying both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had a significantly increased UC risk (OR = 3.7; 95% CI, 1.4-9.7). Moreover, those who had ever smoked with both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had the highest UC risk (OR = 8.6; 95% CI: 2.5-29.7). Conclusions: These findings suggest that NQO1 and SULT1A1 polymorphisms are associated with the risk of UC, particularly among those who have ever smoked.

AB - Purpose: To investigate whether the NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms are associated with urothelial cancer (UC) risk in Taiwan. Methods: In this study, 600 study subjects (including 300 UC patients and 300 cancer-free controls) were recruited from September 1998 to December 2005. We analyzed the NQO1 and SULT1A1 polymorphisms by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. A comprehensive interview was conducted to collect information, including baseline characteristics and cigarette smoking status. We used an unconditional multivariate logistic regression to calculate the odds ratio (OR) and 95% confidence interval (CI). Results: We found a significantly increased UC risk in study subjects with the NQO1 C/T and T/T genotypes (OR = 1.5; 95% CI: 1.03-2.1). A significantly increased UC risk was found in those with the SULT1A1 G/G genotype (OR = 2.0; 95% CI: 1.3-3.2). Subjects who had ever smoked with either the NQO1 C/T and T/T genotypes or the SULT1A1 G/G genotype had significantly increased UC risks, showing ORs of 3.0 and 5.3, respectively. Subjects carrying both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had a significantly increased UC risk (OR = 3.7; 95% CI, 1.4-9.7). Moreover, those who had ever smoked with both the NQO1 C/T and T/T genotypes and the SULT1A1 G/G genotype had the highest UC risk (OR = 8.6; 95% CI: 2.5-29.7). Conclusions: These findings suggest that NQO1 and SULT1A1 polymorphisms are associated with the risk of UC, particularly among those who have ever smoked.

KW - Cigarette smoking

KW - NAD(P)H:quinone oxidoreductase 1

KW - Sulfotransferase 1A1

KW - Urothelial cancer

KW - Cigarette smoking

KW - NAD(P)H:quinone oxidoreductase 1

KW - Sulfotransferase 1A1

KW - Urothelial cancer

UR - http://www.scopus.com/inward/record.url?scp=36849049202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849049202&partnerID=8YFLogxK

U2 - 10.1007/s00432-007-0271-4

DO - 10.1007/s00432-007-0271-4

M3 - Article

C2 - 17619904

AN - SCOPUS:36849049202

VL - 134

SP - 203

EP - 209

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 2

ER -